Levalbuterol is not stronger than albuterol in any clinically meaningful way. It contains only the active half of the albuterol molecule, so it’s prescribed at roughly half the dose, but the end result for your airways is essentially the same. A systematic review and meta-analysis comparing the two found no superiority of levalbuterol over albuterol for lung function improvement, oxygen levels, respiratory rate, side effects, or time spent in emergency care.
Why Levalbuterol Exists
Standard albuterol (sometimes called racemic albuterol) is a 50/50 mix of two mirror-image molecules. One of those molecules, the R-isomer, is the one that actually relaxes airway muscles and opens your breathing passages. The other, the S-isomer, doesn’t contribute to bronchodilation and was thought to potentially cause airway inflammation by triggering certain inflammatory pathways in smooth muscle cells.
Levalbuterol is simply the R-isomer isolated on its own, with the S-isomer removed. The idea behind developing it was straightforward: deliver only the “good half” and eliminate any possible interference from the “bad half.” In theory, this would mean a purer, more effective bronchodilator with fewer side effects. In practice, that theoretical advantage hasn’t held up in clinical studies.
What the Clinical Evidence Shows
Head-to-head trials in adults with acute asthma exacerbations have consistently found no significant difference between the two drugs. Lung function improvement, heart rate changes, oxygen saturation, and side effect rates were all statistically similar. The pooled results from a meta-analysis were clear: levalbuterol did not outperform albuterol on any of these measures.
One finding that occasionally gets cited in levalbuterol’s favor is a lower hospitalization rate, but that result was driven almost entirely by a single trial and hasn’t been reliably replicated. It’s not enough evidence to draw a firm conclusion.
Dosing: Half the Milligrams, Same Effect
Because levalbuterol contains only the active isomer, you need a smaller number on the label to get the same bronchodilation. A typical nebulizer dose of levalbuterol is 0.63 mg or 1.25 mg, compared to 2.5 mg for racemic albuterol. This isn’t because levalbuterol is “stronger” per milligram in any special way. It’s because you’re getting 100% active ingredient instead of a 50/50 split. The amount of active drug reaching your airways is comparable.
Metabolic side effects illustrate this point well. In pediatric trials, 1.25 mg of levalbuterol and 2.5 mg of racemic albuterol caused nearly identical spikes in blood sugar (both around a 23% increase) and similar drops in potassium levels. The body responds to equivalent doses of the active molecule in essentially the same way regardless of which product delivers it.
Side Effects Are Similar Too
One of the biggest selling points for levalbuterol was a supposedly cleaner side effect profile, particularly less jitteriness and fewer heart rate spikes. That claim hasn’t been supported by the evidence. Trials comparing the two drugs in acute asthma found no significant differences in tachycardia, tremor, or other common side effects.
An FDA review of levalbuterol in children under 4 specifically noted that “there was no substantial difference in the occurrence of hypokalemia, cardiovascular effects, or hyperglycemia among treatment groups, even though a decrease in β2-agonist associated side effects is an often touted safety benefit.” The agency ultimately did not approve levalbuterol for that age group, partly because the drug failed to show a meaningful benefit over placebo in very young children.
The Cost Difference Is Significant
Where the two drugs differ most is price. A large retrospective study using Medicaid data found that annual spending on levalbuterol was approximately five times higher than albuterol ($272 versus $56 per year, adjusted for inflation). For a medication that performs the same in clinical trials, that’s a substantial gap. Albuterol is available as a generic in multiple inhaler and nebulizer formulations, which keeps its cost low. Levalbuterol options are more limited and more expensive.
When Levalbuterol Might Still Be Prescribed
Some people report that levalbuterol feels better subjectively, causing less shakiness or racing heart. Individual responses to medications vary, and if you’ve had a noticeably bad experience with standard albuterol, your provider may try levalbuterol to see if you tolerate it better. This is a reasonable clinical decision even if the population-level data doesn’t show a difference, because averages don’t capture every individual’s experience.
That said, major asthma guidelines have not issued a preference for levalbuterol over racemic albuterol. For the vast majority of people with asthma or other conditions that cause airway tightening, standard albuterol works just as well, costs far less, and is widely available. The two medications open your airways by the same mechanism, at equivalent doses of active drug, with the same side effect profile. Levalbuterol isn’t stronger. It’s the same active ingredient, repackaged.